Paintaud G - Search Results

1

Panitumumab and cetuximab affect differently miRNA expression in colorectal cancer cells.

Chautard R, Corset L, Ibrahim S, Desvignes C, Paintaud G, Baroukh N, Guéguinou M, Lecomte T, Raoul W. Chautard R, et al. Among authors: paintaud g. Biomark Med. 2021 Jun;15(10):685-696. doi: 10.2217/bmm-2020-0520. Epub 2021 Jun 25. Biomark Med. 2021. PMID: 34169732

2

[Target antigens for therapeutic antibodies in oncology: many candidates, few successes].

Ceze N, Probst A, Lecomte T, Ohresser M, Paintaud G, Watier H. Ceze N, et al. Among authors: paintaud g. Bull Cancer. 2007;94(7 Suppl):F129-36. Bull Cancer. 2007. PMID: 17964990 Review. French.

3

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab.

Cézé N, Ternant D, Piller F, Degenne D, Azzopardi N, Dorval E, Watier H, Lecomte T, Paintaud G. Cézé N, et al. Among authors: paintaud g. Ther Drug Monit. 2009 Oct;31(5):597-601. doi: 10.1097/FTD.0b013e3181b33da3. Ther Drug Monit. 2009. PMID: 19730278

4

An enzyme-linked immunosorbent assay to study bevacizumab pharmacokinetics.

Ternant D, Cézé N, Lecomte T, Degenne D, Duveau AC, Watier H, Dorval E, Paintaud G. Ternant D, et al. Among authors: paintaud g. Ther Drug Monit. 2010 Oct;32(5):647-52. doi: 10.1097/FTD.0b013e3181ef582a. Ther Drug Monit. 2010. PMID: 20720519

5

Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients.

Azzopardi N, Lecomte T, Ternant D, Boisdron-Celle M, Piller F, Morel A, Gouilleux-Gruart V, Vignault-Desvignes C, Watier H, Gamelin E, Paintaud G. Azzopardi N, et al. Among authors: paintaud g. Clin Cancer Res. 2011 Oct 1;17(19):6329-37. doi: 10.1158/1078-0432.CCR-11-1081. Epub 2011 Sep 27. Clin Cancer Res. 2011. PMID: 21953502 Clinical Trial.

6

Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies.

Passot C, Azzopardi N, Renault S, Baroukh N, Arnoult C, Ohresser M, Boisdron-Celle M, Gamelin E, Watier H, Paintaud G, Gouilleux-Gruart V. Passot C, et al. Among authors: paintaud g. MAbs. 2013 Jul-Aug;5(4):614-9. doi: 10.4161/mabs.24815. Epub 2013 Apr 25. MAbs. 2013. PMID: 23751752 Free PMC article. Clinical Trial.

7

Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration.

Desvignes C, Edupuganti SR, Darrouzain F, Duveau AC, Loercher A, Paintaud G, Mulleman D. Desvignes C, et al. Among authors: paintaud g. Bioanalysis. 2015;7(10):1253-60. doi: 10.4155/bio.15.30. Bioanalysis. 2015. PMID: 26045004

8

Pharmacokinetics of adalimumab in Crohn's disease.

Ternant D, Karmiris K, Vermeire S, Desvignes C, Azzopardi N, Bejan-Angoulvant T, van Assche G, Paintaud G. Ternant D, et al. Among authors: paintaud g. Eur J Clin Pharmacol. 2015 Sep;71(9):1155-7. doi: 10.1007/s00228-015-1892-1. Epub 2015 Jun 27. Eur J Clin Pharmacol. 2015. PMID: 26115613 Free article. No abstract available.

9

A robust estimation of infliximab pharmacokinetic parameters in Crohn's disease.

Aubourg A, Picon L, Lecomte T, Bejan-Angoulvant T, Paintaud G, Ternant D. Aubourg A, et al. Among authors: paintaud g. Eur J Clin Pharmacol. 2015 Dec;71(12):1541-2. doi: 10.1007/s00228-015-1942-8. Epub 2015 Sep 15. Eur J Clin Pharmacol. 2015. PMID: 26369535 No abstract available.

10

Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab.

Rollin J, Payancé A, Gouilleux-Gruart V, Boisdron-Celle M, Azzopardi N, Morel A, Gruel Y, Paintaud G, Gamelin E, Watier H, Lecomte T. Rollin J, et al. Among authors: paintaud g. Pharmacogenomics. 2015 Dec;16(18):2035-43. doi: 10.2217/pgs.15.139. Epub 2015 Nov 30. Pharmacogenomics. 2015. PMID: 26615857 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page